PWS
AGN

Peloton Wealth Strategists’s Allergan Inc AGN Stock Holding History

Peloton Wealth Strategists’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-14,028
Closed -$2.98M – 82
2014
Q4 		$2.98M Sell
14,028
-1,122
-7% -$223K 2.27% 10
2014
Q3 		$2.7M Buy
+15,150
New +$2.52M 2.13% 13
2014
Q2 		– Sell
-20,600
Closed -$2.56M – 108
2014
Q1 		$2.56M Hold
20,600
– – 2.1% 15
2013
Q4 		$2.29M Sell
20,600
-1,100
-5% -$105K 1.85% 20
2013
Q3 		$1.96M Buy
21,700
+1,350
+7% +$121K 1.65% 28
2013
Q2 		$1.71M Buy
+20,350
New +$2.11M 1.54% 31

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Peloton Wealth Strategists's AGN Position: Q1 2015 in Review

Peloton Wealth Strategists sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 14,028 shares — an estimated $2.98M sold.

Peloton Wealth Strategists first reported a position in AGN in Q2 2013 and held it in 6 quarters. The position peaked at $2.98M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Peloton Wealth Strategists reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Peloton Wealth Strategists sold 14,028 Allergan Inc shares in Q1 2015, an estimated $2.98M.
  • Peloton Wealth Strategists first reported a position in Allergan Inc in Q2 2013 and held it in 6 quarters.
  • Peloton Wealth Strategists's Allergan Inc position peaked at $2.98M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Peloton Wealth Strategists's 13F filing for Q1 2015, filed 15 May 2015.